Tagged With Bristol-myers Squibb

Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it's part of a plan to get Celgene's mega-merger with Bristol-Myers Squibb approved


Bristol-Myers Squibb is selling off a blockbuster drug to help its $74 billion merger with Celgene get approved — and now both stocks are tumbling


Dispensed: Pharma CEOs on Capitol Hill, the exploding CBD market, and treating kids with new models of primary care



Opposition to Bristol-Myers Squibb's $74 billion acquisition of Celgene could endanger the deal, and the whole situation is 'somewhat unprecedented'


Bristol-Myers' record-breaking $74 billion biotech deal is in jeopardy


The biggest healthcare investor conference starts on Monday — here are the top 5 areas we're keeping an eye on



Dispensed: A $74 billion mega-merger starts 2019 off with a bang and how a health system plans to disrupt itself before it's disrupted


Bristol-Myers Squibb is buying Celgene in a $74 billion deal


'We are going to have lung cancer patients living longer and better': A new kind of cancer treatment is about to change how we treat the disease


2 cancer drugmakers just presented key data about how new treatments work in lung cancer -- and the markets picked a winner


We're about to get some key lung cancer data -- and it could affect how hundreds of thousands of cancer patients are treated


Pharma giant Bristol-Myers Squibb just made another big bet on cancer immunotherapy



A small drug company that's trying to make cancer treatments safer just received a huge endorsement


Carl Icahn just jumped into a $90 billion drug maker, and people are betting it will be a takeover target


Carl Icahn has reportedly taken a stake in Bristol-Myers and its shares are jumping


An apology to Medarex CEO Howard Pien, 7 years in the making



There's a major roadblock to one of the most talked about new cancer therapies


The FDA just approved an immune-system-stimulating blood cancer drug


The FDA is quickly giving this cancer drug approval for new uses


Drug makers are interested in an ancient Chinese medicine after Harvard found out how it works